JRMO manuscript editing requirements
- Word format
- Page numbering – bottom middle of page
- Text: Times New Roman size 12, spacing 1.5 lines
- Page: A4, normal margins (2,54 cm top, bottom, left, right)
- Abstract (150 – 250 words)
- Keywords (4 – 6)
- Headings and subheading
The title page should include:
- A concise and informative title
- The name(s) of the author(s)
- The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
- A clear indication and an active e-mail address of the corresponding author marked with a star * in author list and detailed before the abstract.
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
Trial registration number and date of registration if available
Please provide 4 to 6 keywords which can be used for indexing purposes.
Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file. Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type. Add permissions to reproduce the figures and references if applicable.
All tables are to be numbered using Arabic numerals. Tables should always be cited in text in consecutive numerical order. For each table, please supply a table caption (title) explaining the components of the table.
All manuscripts must contain the following sections at the end, under the heading ‘Declarations’
. If any of the sections are not relevant to your manuscript, please include the heading and write ‘Not applicable’ for that section:
- Funding (information that explains whether and by whom the research was supported)
- Conflicts of interest/Competing interests (include appropriate disclosures)
- Ethics approval (include appropriate approvals or waivers)
- Consent to participate (include appropriate statements)
- Consent for publication (include appropriate statements)
- Availability of data and material (data transparency)
- Authors’ contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
- Acknowledgments. Acknowledgments of people, grants, funds, etc. should be placed at the end of the manuscript. The names of funding organizations should be written in full.
Types of articles:
- Required style: Vancouver. Preferrablyuse a reference editor: Mendeley®, Endnote®, Zotero®, or alternatively by the function of Word → References →Insert Endnote (use arabic numerals for manually inserted endote references).
- Original articles should describe original experimental work according to the standard scientific format: Title page; abstract; keywords; abbreviations; introduction; materials and methods; results; discussion; references, figures and legends.
JRMO does not have obligatory length restrictions. However, as a guideline, the length of a research article should not exceed 12 typeset pages, including figures, tables and references (a printed page contains approx. 1000 words or 40 references). Shorter manuscripts will be preferred when print issues are compiled.
- Review Articles. Reviews are usually solicited by a personal invitation to the author. However, unsolicited reviews are considered as well, and subjected to the same evaluation process. Reviews should be overviews of recent developments in research fields of general interest, with a fair representation of different aspects of the topic. The format, including introduction, headings, subheadings, and discussion, will vary depending on the subject. Reviews should not contain unpublished original results of the author.
JRMO does not have obligatory length restrictions. However, as a guideline, the length of a review article should not exceed 20 typeset pages, including figures, tables and references (a printed page contains approx. 1000 words or 40 references). Shorter manuscripts will be preferred when print issues are compiled. PRISMA guidelines should be followed when writing systematic reviews.
- Letters and Comments. In addition to manuscripts, letters or comments discussing an article published in the past 6 months in JRMO are welcome and may appear in print in one of the following issues. Each comment will be sent to the corresponding author of the discussed article together with an invitation to respond. The comment and the reply may be sent to an independent referee. However, the editor-in-chief will make the final decision whether the correspondence will be published. JRMO allows the original author a deadline of two weeks to reply. If no answer is received within this timeframe, the editor-in-chief will decide if the letter or comment will be published without response. Letters and comments may be edited and shortened for reasons of clarity and space.
In order to avoid long disputes, only the original comment together with the author’s response will be published. Any additional comments or remarks should be sent to the authors directly and will not further be handled by JRMO
Letters and comments should not exceed 2-3 typed, double spaced pages with only a few essential references, if necessary. Figures should be avoided, unless there is a special need to clarify the written content. A separate page should include a short title, the writer’s name and affiliations, as well as the exact citation of the article commented on.
- Special Sections The special sections “Perspective Reflections” and “Retrospections of a Senior Scientist” provide a forum for discussing expert opinions, considerations and suggestions by leading scientists who have made important contributions and whose advice may be inspiring and educational to the young scientific generation.Contributions in these sections must refer to a subject within the scope of JRMO (oncology, radiotherapy, cancer immunotherapy, cancer biochemistry, cancer cell biology, molecular genetics of cancer, molecular and cellular aspects of cancer, cancer immunology, pharmacology of cancer).
” This type of article provides a forum for expert opinions on recent developments in research fields of general interest, including the opportunity of informed speculation on present and future developments. “Visions and reflections” articles are usually solicited by a personal invitation. However, unsolicited manuscripts are considered as well. In that case the editorial staff will decide on the general suitability of the paper for JRMO. Manuscripts found unsuitable will be returned to the authors within less than a week. All manuscripts are subject to peer review by at least two external reviewers. JRMO does not have obligatory length restrictions. However, as a guideline, the length of a Visions/Reflections article should not exceed 8 typeset pages, including figures, tables and references (a printed page contains approx. 1000 words or 40 references). Shorter manuscripts will be preferred when print issues are compiled.
“Retrospections of a Senior Scientist
” This section contains mostly articles by elderly scientists who recalled their own career and achievements. However, the scope can be directed towards reflections on outstanding scientific discoveries that the authors themselves had made or had been associated with in one way or another. JRMO invites articles dealing with the history of scientific notions (discoveries, theories, paradigms, etc.) that have contributed to or resulted in lasting scientific knowledge, in the laboratory or in practical reality. Contributions are usually invited by the editor-in-chief but unsolicited manuscripts may also be considered. In that case, the editorial staff will decide on the general suitability of the paper for JRMO. Manuscripts found unsuitable will be returned to the authors within less than a week. Final acceptance of all manuscripts in this section is subject to the discretion of the editor-in-chief. JRMO does not have obligatory length restrictions. However, as a guideline, the length of a Memories article should not exceed 8 typeset pages, including figures, tables and references (a printed page contains approx. 1000 words or 40 references). Shorter manuscripts will be preferred when print issues are compiled.
- Case reports. There should be a clear and definite outcome for the case. The discussion section explains the case in the context of relevant information published so far and the appropriate references are cited. The key message summarizes the most important take-away lesson(s) from the case – what the readers should remember. Images should be relevant for the case and have a good resolution. Also, images should have a short title. Case reports can have up to10 images/case. Tables should complement and not repeat the information provided in text. Timeline tables are not mandatory, but they are always a plus for readers. Consider using them when describing the most important dates and times for the case, for example when presenting the clinical findings, treatment and/or outcomes. The case should have between 1000-2500 words. CARE criteria should be followed when writing a case report. Although not mandatory, it is advised to respect the following structure:
The words “case report” should be in the title along with the area of focus
4 to 6 key words that identify areas covered in this case report.
(What is unique about this case? What does it add to the medical literature? The main symptoms of the patient and the important clinical findings. The main diagnoses, therapeutics interventions, and outcomes.What are the main “take-away” lessons from this case?)
One or two paragraphs summarizing why this case is unique with references.
De-identified demographic information and other patient specific information. Main concerns and symptoms of the patient. Medical, family, and psychosocial history including relevant genetic information (also see timeline). Relevant past interventions and their outcomes.
Describe the relevant physical examination (PE) and other significant clinical findings
Important information from the patient’s history organized as a timeline.
Diagnostic methods (such as PE, laboratory testing, imaging, surveys). Diagnostic challenges (such as access, financial, or cultural). Diagnostic reasoning including other diagnoses considered. Prognostic characteristics (such as staging in oncology) where applicable.
Therapeutic Intervention. (
Types of intervention (such as pharmacologic, surgical, preventive, self-care). Administration of intervention (such as dosage, strength, duration). Changes in intervention (with rationale).
Follow-up and Outcomes (
Clinician and patient-assessed outcomes (when appropriate) Important follow-up diagnostic and other test results. Intervention adherence and tolerability (How was this assessed?). Adverse and unanticipated events.
Discussion of the strengths and limitations in your approach to this case. Discussion of the relevant medical literature. The rationale for conclusions (including assessment of possible causes). The primary “take-away” lessons of this case report.
When appropriate the patient should share their perspective on the treatments they received.
Provide patient informed consent if requested.